Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Bruxelles  >  Agfa-Gevaert    AGFB   BE0003755692

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

AGFA-GEVAERT : Annual General Meeting of Agfa-Gevaert

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/24/2012 | 02:31pm CET
  • Press Release
  • Mortsel (Belgium)
  • April 24, 2012 02:00

At Agfa-Gevaert's Annual General Meeting today, all the voting points on the agenda were approved. These included the approval of the 2011 financial statements, the allocation of the result as well as the discharge of directors and auditors.

The shareholders also approved the reappointment of De Wilde J Management BVBA, with permanent representative Julien De Wilde, and Christian Leysen as members of the Board of Directors. Finally, the General Meeting resolved, in accordance with article 556 of the Companies Code, to approve the change-of-control provisions, as stipulated in the Facility Agreement dated May 31, 2011 with Fortis Bank SA/NV, ING Belgium SA/NV and KBC Bank NV on the one hand and Agfa HealthCare NV, Agfa Graphics NV and Agfa-Gevaert NV on the other hand.

At the consequent Extraordinary General Meeting today - all the voting points on the agenda, all of them regarding changes in the articles of association - were approved, except for voting point n°3 regarding the spread in time of the variable remuneration.


Viviane Dictus
Director Corporate Communication
Septestraat 27
2640 Mortsel - Belgium
tel+32 (0) 3 444 7124
fax+32 (0) 3 444 4485
viviane.dictus@agfa.com
Johan Jacobs
Corporate Press Relations Manager
Septestraat 27
2640 Mortsel - Belgium
tel+32 (0) 3 444 8015
fax+32 (0) 3 444 4485
johan.jacobs@agfa.com
distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AGFA-GEVAERT
01/20 AGFA GEVAERT : Publication of a transparency notification - Regulated informatio..
01/19 AGFA GEVAERT : Publication of a transparency notification – Regulated info..
01/19 AGFA-GEVAERT : Publication of a transparency notification - Regulated informatio..
01/19 AGFA GEVAERT : upgrades Jeti Mira with UV LED curing, 3D lens printing
01/16 AGFA GEVAERT : Special Notice - AGFA SOLE SOURCE
01/09 AGFA GEVAERT : Publication of a transparency notification – Regulated info..
01/09 AGFA-GEVAERT : Classic Fund Management AG - Publication of a transparency notifi..
01/09 AGFA GEVAERT : Foreign-Trade Zone (FTZ) 44--Morris County, New Jersey; Notificat..
01/09 AGFA GEVAERT : Foreign-Trade Zones Board Issues Notice on Proposed Production Ac..
2016 COMPUGROUP MEDICAL : Agfa ends talks with its potential buyer
More news
Sector news : Advanced Medical Equipment & Technology - NEC
01/19 Davos CEOs 'go local' on supply chain in Trump era
01/08DJCorrection to Parkinson's Therapy Story
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
01/08DJParkinson's Therapy Gets Fresh Look From Device Makers
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
2016 Agfa-Gavaert's (AFGVF) CEO Christian Reinaudo on Q1 2017 Results - Earnings C..
2016 Agfa-Gavaert NV 2016 Q3 - Results - Earnings Call Slides
2016 Agfa-Gavaert NV beats by ?0.01, misses on revenue
2016 Agfa-Gavaert's (AFGVF) CEO Christian Reinaudo on Q2 2016 Results - Earnings C..
2016 Agfa-Gavaert NV 2016 Q2 - Results - Earnings Call Slides
Advertisement
Financials (€)
Sales 2016 2 536 M
EBIT 2016 195 M
Net income 2016 101 M
Finance 2016 1,50 M
Yield 2016 -
P/E ratio 2016 5,68
P/E ratio 2017 7,36
EV / Sales 2016 0,24x
EV / Sales 2017 0,19x
Capitalization 620 M
More Financials
Chart AGFA-GEVAERT
Duration : Period :
Agfa-Gevaert Technical Analysis Chart | AGFB | BE0003755692 | 4-Traders
Full-screen chart
Technical analysis trends AGFA-GEVAERT
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 3,80 €
Spread / Average Target 5,4%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Christian Reinaudo President, Chief Executive Officer & Director
Julien de Wilde Chairman
Kris Hoornaert Chief Financial Officer
Jozef Cornu Non-Executive Director
Willy W. Duron Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
AGFA-GEVAERT-1.80%663
THERMO FISHER SCIENTIF..1.71%56 690
DANAHER CORPORATION3.46%55 703
BOSTON SCIENTIFIC CORP..10.49%32 544
PHILIPS-3.72%27 770
INTUITIVE SURGICAL, IN..3.56%25 447
More Results